We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Patient Guidelines Issued by European Asthma Group

By HospiMedica staff writers
Posted on 20 May 2002
An asthma patient manifesto has been issued by a European asthma group that calls for national patient groups, health-care professionals, and policy makers to help implement a program of changes that will improve the quality of life for asthma patients worldwide. More...
The manifesto was issued during the recent 7th Annual Congress of the European Federation of Asthma and Allergy Associations (EFA, Brussels, Belgium; www.efanet.org) held in Visegrad, Hungary.

"More than 150 million people suffer from asthma across the world. This is the first manifesto that addresses asthma from their perspective,” said professor Erkka Valovirta, president of the EFA. "Patients are often unaware of the goals of long-term asthma management, as put forward in professional guidelines.”

The manifesto highlights the need for asthma patients to have easy-to-understand information, regular contact with their doctor, and a personalized treatment plan that clarifies the importance of regular inhaled corticosteroid treatment. Because patients do not always fully understand their medication, they are often overly reliant on their bronchodilators. New advances in maintenance treatments, which include single inhalers with adjustable dosing, can improve overall control. Prevention is also an important aspect of asthma control. The manifesto calls upon pan-European and national governments to take immediate action on air pollution as a necessary step in preventing asthma attacks and reducing prevalence.

The EFA, formed by eight European countries in 1991, now represents 19 countries and has become one of the most important patient associations in Europe.




Related Links:
EFA

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
ow Frequency Pulse Massager
ET10 L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.